Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy
The Journal of Allergy and Clinical Immunology | Sep 07, 2017
CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen: A systematic review and meta-analysis of randomized, controlled trials
Clinical Journal of the American Society of Nephrology | Sep 07, 2017
Most read this week